Taligen Therapeutics' Acquisition

Taligen Therapeutics was acquired by Alexion Pharmaceuticals on January 31, 2011.

Taligen Therapeutics is a development-stage biotechnology company. In January 2011, Taligen Therapeutics was acquired by Alexion Pharmaceuticals. The valuation of Taligen Therapeutics was $111 millio…

Articles about Taligen Therapeutics' Acquisition: